
Glystek M 1mg/500mg Tablet
Marketer
Aristek Pharma Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glystek M 1mg/500mg Tablet
Diabetac Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Always take Diabetac Duo with food, consistently at the same time daily for optimal effectiveness. Your physician will determine the appropriate dosage, potentially adjusting it based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking complications like kidney impairment, vision loss, neuropathy, and limb loss. Remember, this medication is part of a comprehensive approach including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are key to diabetes management. Hypoglycemia (low blood sugar) is the most common adverse effect, characterized by sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to lower blood sugar. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also a potential consequence. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Glystek M 1mg/500mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Glystek M 1mg/500mg Tablet
Managing Type 2 Diabetes
Major Benefits of Glystek M 1mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Glystek M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Glystek M 1mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glystek M 1mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glystek M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Glystek M 1mg/500mg Tablet works:
Glystek M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and improving insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glystek M 1mg/500mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Glystek M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Always seek medical advice.
Breast feedingUNSAFE
Use of Glystek M 1mg/500mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glystek M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glystek M 1mg/500mg tablet use. Physician consultation is necessary. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glystek M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Glystek M 1mg/500mg tablets are typically initiated at a reduced dosage; however, their use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glystek M 1mg/500mg Tablet :
Should you forget a Glystek M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glystek M 1mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
